Intelicanna Ltd (INTL) - Cash Flow Conversion Efficiency

Latest as of December 2022: -0.025x

Based on the latest financial reports, Intelicanna Ltd (INTL) has a cash flow conversion efficiency ratio of -0.025x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-194.89 Million ≈ $-522.48K USD) by net assets (ILA7.77 Billion ≈ $20.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Intelicanna Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Intelicanna Ltd - Cash Flow Conversion Efficiency Trend (2012–2022)

This chart illustrates how Intelicanna Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Intelicanna Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intelicanna Ltd ranked by their cash flow conversion efficiency. Explore Intelicanna Ltd (INTL) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Jiankun International Bhd
KLSE:8923
-0.018x
Coil S.A./N.V
PA:ALCOI
0.006x
STRATHMORE PLUS URANIUM
F:TO3
-0.068x
Zonte Metals Inc
V:ZON
0.000x
Nala Digital Commerce Ltd
TA:SEFA
0.343x
Intuitive Investments Group Plc
LSE:IIG
-0.025x
Kanger International Bhd
KLSE:0170
-0.041x
APOLLO GROUP-A
F:APO
0.090x

Annual Cash Flow Conversion Efficiency for Intelicanna Ltd (2012–2022)

The table below shows the annual cash flow conversion efficiency of Intelicanna Ltd from 2012 to 2022. View latest Intelicanna Ltd stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2022-12-31 ILA7.77 Billion
≈ $20.84 Million
ILA-286.06 Million
≈ $-766.91K
-0.037x -166.91%
2021-12-31 ILA6.78 Billion
≈ $18.17 Million
ILA372.78 Million
≈ $999.41K
0.055x +110.63%
2020-12-31 ILA7.04 Billion
≈ $18.88 Million
ILA-3.64 Billion
≈ $-9.77 Million
-0.518x -2543.55%
2019-12-31 ILA8.07 Billion
≈ $21.64 Million
ILA-158.05 Million
≈ $-423.74K
-0.020x +91.86%
2018-12-31 ILA7.19 Billion
≈ $19.28 Million
ILA-1.73 Billion
≈ $-4.64 Million
-0.240x -63.55%
2017-12-31 ILA6.87 Billion
≈ $18.42 Million
ILA-1.01 Billion
≈ $-2.71 Million
-0.147x -581.67%
2016-12-31 ILA5.99 Billion
≈ $16.07 Million
ILA182.92 Million
≈ $490.39K
0.031x +106.88%
2015-12-31 ILA4.91 Billion
≈ $13.17 Million
ILA-2.18 Billion
≈ $-5.84 Million
-0.444x +24.51%
2014-12-31 ILA4.89 Billion
≈ $13.12 Million
ILA-2.88 Billion
≈ $-7.71 Million
-0.588x -1336.24%
2013-12-31 ILA4.41 Billion
≈ $11.84 Million
ILA-180.63 Million
≈ $-484.25K
-0.041x +58.50%
2012-12-31 ILA33.29 Billion
≈ $89.24 Million
ILA-3.28 Billion
≈ $-8.80 Million
-0.099x --

About Intelicanna Ltd

TA:INTL Israel Drug Manufacturers - Specialty & Generic
Market Cap
$6.41 Million
ILA2.39 Billion ILA
Market Cap Rank
#28180 Global
#403 in Israel
Share Price
ILA50.90
Change (1 day)
+2.21%
52-Week Range
ILA42.90 - ILA114.90
All Time High
ILA11460.00
About

Intelicanna Ltd operates as pharmaceutical company in Israel. It grows, cultivates, produces, research, markets, and sells medical cannabis. The company was formerly known as Tefen Industrial Engineering & Management & Systems Analysis and changed its name to Intelicanna Ltd in March 2019. The company was founded in 1981 and is headquartered in Hod Hasharon, Israel.